|
|
 |
|
Viewing report
|
|
|
|
Targeted Botanical and Herbal Food and Drinks in Europe
Business Insights, Jan 2011, Pages: 72
The demand for healthy food and drinks has created a significant opportunity for botanicals to act as functional ingredients. However, with the adoption of new health claims legislation in Europe, manufacturers must reevaluate their approach to NPD. This report analyzes the impact of new health claims legislation on the botanical and herbal food and drinks industry. By examining the current product launch landscape and existing health claims and clinical data, manufacturers can assess the potential of specific botanicals.
Scope of this research
- Identify the leading botanicals currently used in food and drinks products.
- Examine examples of product innovation in the botanical foods industry.
- Analyze the therapeutic areas being targeted by food and drinks manufacturers through product launches and health claims submissions.
- Assess the potential of specific herbs and botanicals as indicated by research, manufacturing and health claim activities.
- Understand the impact of a more stringent regulatory environment and how it impacts which botanical and herbal ingredients to use.
Research and analysis highlights
Among the various claims made on new product launches made through to August 2010, 49% were targeted at the metabolic/endocrinology therapeutic area, with weight management being the main area of focus. The World Health Organization estimates that worldwide there are over one billion overweight adults, of which 300 million are obese.
Other than probiotics, botanicals and herbs have been least successful area in securing positive approvals from EFSA. Of the 67 opinions published pertaining to botanicals and herbs in the first two batches, 66 have been rejected.
Botanicals have temporarily been removed from EFSA's assessment process creating uncertainty over the future regulatory environment. With the EC contemplating the adoption of an alternative assessment procedure, it could still be possible for previously rejected health claims to successfully reach the market via an updated evaluation process.
Key reasons to purchase this research
- Which botanicals are used most frequently as ingredients in new product launches?
- Which therapeutic areas are targeted the most by recent product launches and health claim submissions?
- How will the introduction of EFSA's new regulations affect innovation in terms of the use of botanicals in food and drinks products?
- Which botanicals have the greatest potential in future health claims-based food and drinks products and why?
- Why are the new regulations so critical in understanding the wider functional foods industry?
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
